A diagnostic and therapeutic scheme for a solitary cysticercus granuloma

Neurology

Volumn 75, Issue 24, 2010, Pages 2236-2245

  Singh, G ^a   Rajshekhar, V ^b   Murthy, J M K ^c   Prabhakar, S ^d   Modi, M ^d   Khandelwal, N ^d   Garcia, H H ^e,f  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c CARE HOSPITAL   (India)

^d POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^f INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE; PHENYTOIN; PRAZIQUANTEL; PREDNISOLONE;

ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; GRANULOMA; HUMAN; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAPSE; SEIZURE; SOLITARY CYSTICERCUS GRANULOMA; TREATMENT DURATION;

EID: 78650831925     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820202dc     Document Type: Review

References (59)

1. Rajshekhar V, Joshi DD, Doanh NQ, van De N, Xia-onong Z. Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues. Acta Trop 2003;87:53-60.
2. Garcia HH, Gonzalez AE, Gilman RH. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis 2003;16:411-419.
3. Ong S, Talan DA, Moran GJ, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002;8:608-613.
4. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2004;63:1559-1564.
5. McCormick GF, Zee CS, Heiden J. Cysticercosis cerebri. Review of 127 cases Arch Neurol 1982;39:534-539.
6. Garcia HH, Del Brutto OH. Taenia solium cysticercosis. Infect Dis Clin North Am 2000;14:97-119.
7. Del Brutto OH. Single parenchymal brain cysticercus in the acute encephalitic phase: definition of a distinct form of neurocysticercosis with a benign prognosis. J Neurol Neurosurg Psychiatry 1995;58:247-249.
8. Rajashekhar V. Solitary cerebral cysticercus granuloma. Epilepsia 2003;44(suppl 1):25-28.
9. Garcia HH, Del Brutto OH. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers: The Cysticercosis Working Group in Peru. Neurology 1999;53:1582-1584.
10. Del Brutto OH, Zenteno MA, Salgado P, Sotelo J. MR imaging in cysticercotic encephalitis. AJNR Am J Neuro-radiol 1989;10:S18-S20.
11. Rangel R, Torres B, Del Bruto O, Sotelo J. Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg 1987;36:387-392.
12. Rio de la Loza LJ, Meza EL. Cysticercotic encephalitis: case report of miliary infestation in an encephalopathic fashion. Arch Neurol 2008;65:276-277.
13. Garcia HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Micro-biol Rev 2002;15:747-756.
14. Singh G, Singh P, Singh I, Rani A, Kaushal S, Avasthi G. Epidemiologic classification of seizures associated with neurocysticercosis: observations from a sample of seizure disorders in neurologic care in India. Acta Neurol Scand 2006;113:233-240.
15. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991;84:465-470.
16. Mitchell WG, Crawford TO. Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. Pediatrics 1988;82:76-82.
17. Murthy JM, Yangala R. Etiological spectrum of symptomatic localization related epilepsies: a study from South India. J Neurol Sci 1998;158:65-70.
18. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antip-arasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-258.
19. Carpio A, Kelvin EA, Bagiella E, et al. Effects of albenda-zole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2008;79: 1050-1055.
20. Kaur S, Singhi P, Singhi S, Khandelwal N. Combination therapy with albendazole and praziquantel versus albenda-zole alone in children with seizures and single lesion neuro-cysticercosis: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J 2009;28:403-406.
21. de Souza A, Thennarasu K, Yeshraj G, Kovoor JM, Nalini A. Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cystic-ercal lesion: effect on long-term seizure outcome. J Neurol Sci 2009;276:108-114.
22. Gogia S, Talukdar B, Choudhury V, Arora BS. Neurocys-ticercosis in children: clinical findings and response to al-bendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg 2003;97:416-421.
23. Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr 2003;143:111-114.
24. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994;44: 1344-1346.
25. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Al-bendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J 1998;17:696-700.
26. Garg RK, Potluri N, Kar AM, et al. Short course of pred-nisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. J Infect 2006;53: 65-69.
27. Mall RK, Agarwal A, Garg RK, Kar AM, Shukla R. Short course of prednisolone in Indian patients with solitary cys-ticercus granuloma and new-onset seizures. Epilepsia 2003;44:1397-1401.
28. Singhi P, Jain V, Khandelwal N. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticer-cosis. J Child Neurol 2004;19:323-327.
29. Verma A, Misra S. Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurol Scand 2006;113:174-177.
30. Thussu A, Arora A, Prabhakar S, Lal V, Sawhney IM. Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs? Neurol India 2002; 50:141-144.
31. Prakash S, Garg RK, Kar AM, et al. Intravenous methyl prednisolone in patients with solitary cysticercus granu-loma: a random evaluation. Seizure 2006;15:328-332.
32. Kishore D, Misra S. Short course of oral prednisolone on disappearance of lesion and seizure recurrence in patients of solitary cysticercal granuloma with single small enhancing CT lesion: an open label randomized prospective study. J Assoc Physicians India 2007;55:419-424.
33. Riviello JJ, Jr., Ashwal S, Hirtz D, et al. Practice parameter: diagnostic assessment of the child with status epilepti-cus (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2006;67:1542-1550. (Pubitemid 44747921)
34. French J, Gronseth G. Lost in a jungle of evidence: we need a compass. Neurology 2008;71:1634-1638.
35. Gronseth G, French J. Practice parameters and technology assessments: what they are, what they are not, and why you should care. Neurology 2008;71:1639-1643.
36. Rajshekhar V, Chandy MJ. Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol Scand 1997;96: 76-81.
37. Rajshekhar V. Rate of spontaneous resolution of a solitary cysticercus granuloma in patients with seizures. Neurology 2001;57:2315-2317.
38. Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 2004;62:2236-2240.
39. Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002;59:1730-1734.
40. Rajshekhar V, Chandy MJ. Comparative study of CT and MRI in patients with seizures and a solitary cerebral cystic-ercus granuloma. Neuroradiology 1996;38:542-546.
41. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immu-noelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989;159:50-59.
42. Prabhakaran V, Rajshekhar V, Murrell KD, Oommen A. Conformation-sensitive immunoassays improve the sero-diagnosis of solitary cysticercus granuloma in Indian patients. Trans R Soc Trop Med Hyg 2007;101:570-577.
43. Singh G, Kaushal V, Ram S, Kaushal RK, Dhanuka AK, Khurana S. Cysticercus immunoblot assay in patients with single, small enhancing lesions and multilesional neurocys-ticercosis. J Assoc Physicians India 1999;47:476-479.
44. Rajshekhar V, Wilson M, Schantz PM. Cysticercus immu-noblot assay in Indian patients with single small enhancing CT lesions. J Neurol Neurosurg Psychiatry 1991;54:561-562.
45. Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albenda-zole and praziquantel. Ann Intern Med 2006;145:43-51.
46. Sharma SR AA, Kar AM, Shukla Rakesh, Garg RK. Evaluation of role of steroid alone and with albendazole in patients of epilepsy with single-small enhancing computerized tomography lesions. Ann Indian Acad Neurol 2007;10:39-43.
47. Thussu A, Chattopadhyay A, Sawhney IM, Khandelwal N. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. J Neurol Neurosurg Psychiatry 2008;79:272-275.
48. Rajshekhar V. Incidence and significance of adverse effects of albendazole therapy in patients with a persistent solitary cysticercus granuloma. Acta Neurol Scand 1998;98:121-123.
49. Singla M. Short course of prednisolone in solitary cysticercus granuloma [postgraduate thesis]. Chandigarh, India: Postgraduate Institute of Medical Education and Research; 2009.
50. Gupta M, Agarwal P, Khwaja GA, et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurol India 2002;50:145-147.
51. Kaushal S, Rani A, Chopra SC, Singh G. Safety and efficacy of clobazam versus phenytoin-sodium in the antiepi-leptic drug treatment of solitary cysticercus granulomas. Neurol India 2006;54:157-160.
52. Bittencourt PR, Gracia CM, Martins R, Fernandes AG, Diekmann HW, Jung W. Phenytoin and carbamazepine decreased oral bioavailability of praziquantel. Neurology 1992;42:492-496.
53. Lanchote VL, Garcia FS, Dreossi SA, Takayanagui OM. Pharmacokinetic interaction between albendazole sulfox-ide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Ther Drug Monit 2002;24:338-345.
54. Pradhan S, Kathuria MK, Gupta RK. Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neu-rocysticercosis. Ann Neurol 2000;48:181-187.
55. Chandy MJ, Rajshekhar V, Prakash S, et al. Cysticercosis causing single, small CT lesions in Indian patients with seizures. Lancet 1989;1:390-391.
56. Rajshekhar V, Chacko G, Haran RP, Chandy MJ, Chandi SM. Clinicoradiological and pathological correlations in patients with solitary cysticercus granuloma and epilepsy: focus on presence of the parasite and oedema formation. J Neurol Neurosurg Psychiatry 1995;59: 284-286.
57. Rajshekhar V, Haran RP, Prakash GS, Chandy MJ. Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy: clinical and computerized tomographic criteria. J Neurosurg 1993;78: 402-407.
58. Thussu A, Arora A, Lal V, Prabhakar S, Sawhney IM. Al-bendazole therapy for solitary persistent cysticercus granu-loma. Neurol India 2001;49:95-97.
59. Wu Z, Mittal S, Kish K, Yu Y, Hu J, Haacke EM. Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging 2009;29:177-182.